期刊文献+

NY-ESO-1和热休克蛋白70融合基因的构建和原核表达

Construction and Prokaryotic Expression of Fusion Gene of NY-ESO-1 and Heat Shock Protein 70
下载PDF
导出
摘要 目的构建热休克蛋白(HSP)70和肿瘤睾丸抗原NY-ESO-1融合基因,并在大肠杆菌中诱导表达。方法应用逆转录聚合酶链反应(RT-PCR)技术,从人肝癌细胞株HepG2扩增HSP70基因,测序后插入pGEX-ESO1质粒中,构建NY-ESO-1与HSP70的N端融合基因原核表达质粒pGEX-ESO1-HSP70,IPTG诱导含有该质粒的大肠杆菌BL21(DE3)表达目的蛋白,Western blot鉴定蛋白的特异性。结果扩增得到长度为1 917 bp的人HSP70全长基因,测序结果表明与GenBank公布的序列一致;获得pGEX-ESO1-HSP70融合基因原核表达质粒,经IPTG诱导,在BL21(DE3)中表达分子量约106 kD的融合蛋白(包括GST 26 kD,NY-ESO1 10 kD,HSP7070 kD),Western blot检测该蛋白可与HSP70特异性结合。结论成功构建pGEX-ESO1-HSP70重组表达质粒,并获得高效表达的ESO1-HSP70融合蛋白,为HSP70-多肽疫苗在肿瘤免疫治疗中的作用奠定基础。 Objective To construct the fusion gene of human NY-ESO-1 and heat shock protein 70(HSP 70) and express the fusion protein in E.coli. Methods The HSP 70 gene was amplified by RT-PCR from HepG2 cell line.After sequencing, HSP70 gene was cloned into the pGEX-ESO1 vector to construct the fusion gene plasmid pGEX-ESO1-HSP70.The BL21(DE3) containing pGEX-ESO1-HSP70 was induced by IPTG.The fusion protein was identified by Western blot.Results The full-length HSP70 gene was amplified from HepG2 cell line,which sequence was identical with that reported in Genbank.The fusion gene plasmid pGEXESO1-HSP70 was constructed.The BL21(DE3) containing the pGEX-ESO1-HSP70 was induced to express a Mr 106 kD fusion protein,which could specifically recognize HSP70 antibody by Western blot.Conclusion The fusion gene plasmid of human NY-ESO-1 and HSP70 was constructed and the fusion protein was expressed successfully.It lays the foundation for HSP-peptide complex vaccines in tumor immunotherapy.
出处 《福建医科大学学报》 2006年第6期550-552,555,共4页 Journal of Fujian Medical University
基金 广州市科技计划基金资助项目(2003J1-C0221)
关键词 热休克蛋白70 NY-ESO-1 融合基因 原核表达 heat shock protein 70 NY-ESO-1 fusion gene prokaryotic expression
  • 相关文献

参考文献11

  • 1[8]萨姆布鲁克 J,拉塞尔D W.分子克隆实验指南[M].北京:科学出版社.2002.
  • 2[2]Binder RJ,Han DK,Srivastava PK.CD91:a receptor for heat shock protein gp96[J].Nat Immunol,2000,1(2):151-155.
  • 3[3]Chen YT,Scanlan MJ,Sahin U,et al.A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening[J].Proc Natl Acad Sci USA,1997,94(5):1914-1918.
  • 4[4]Odunsi K,Jungbluth AA,Stockert E,et al.NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer[J].Cancer Res,2003,63(18):6076-6083.
  • 5[5]Korangy F,Ormandy LA,Bleck JS,et al.Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma[J].Clin Cancer Res,2004,10(13):4332-4341.
  • 6[6]Davis ID,Chen W,Jackson H,et al.Recombination NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans[J].Proc Natl Acad Sci USA,2004,101:10697~10702.
  • 7张文敏,肖刚,张萌,谢丹,郭爱林,文剑明.人NY-ESO-1基因的原核表达、纯化和初步应用[J].中国肿瘤临床,2005,32(11):631-634. 被引量:6
  • 8[8]Janetzki S,Palla D,Rosenhauer V,et al.Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations:A pilot study[J].Int J Cancer,2000,88(2):232-238.
  • 9[9]Cheng WF,Huang CF,Chai CY,et al.Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene[J].J Immunol,2001,166(10):6218-6226.
  • 10[10]Wu Y,Wan T,Zhou X,et al.Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine[J].Cancer Res,2005,65(11):4947-4954.

二级参考文献13

  • 1Jager D, Stockert E, Jager E, et al. Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library[J]. Cancer Res, 2000, 60(13):3584-3591.
  • 2Jager D, Stockert E, Gure AO, et al.Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library [J]. Cancer Res, 2001, 61(5):2055 -2061.
  • 3Jager E, Ghen YT, DrijflaoutJW, et al. Simultaneous humoral and definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes[J]. J Exp Med, 1998, 187(2):265-270.
  • 4Romero P, Dutoit V, Rubio-Godoy V, et al. CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequences [J]. Clin Cancer Res,2001, 7(3 Supple):766-772.
  • 5Stockert E, Jager E, Chen YT, et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens[J].J Exp Med, 1998, 187(8):1349-1354.
  • 6Chen YT, Scanlan MJ, Sahin U, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening []]. Proc Nad Acad Sci USA, 1997, 94 (5):1914-1918.
  • 7Mashino O, Sadanaga N, Tanaka F,et al. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas[J]. Br J Cancer, 2001, 85(5):713-720.
  • 8Odunsi K, Jungbluth AA, Stockert E, et al. NY-ESO-1 and LAGE-1 cancer-testis andgens are potential targets for immunotherapy in epithelial ovarian cancer[]]. Cancer Res, 2003, 63(18): 6076-6083.
  • 9Gnjatic S, Jager E, Ghen W, et al. CD8 (+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients []]. Proc Nail Acad Sci USA, 2002, 99(18):11813-11818.
  • 10Zarour HM, Maillere B, Brusic V,et al.NY-ESO-1 119-143 is promiscuous major histocompatibility complex class H T-helper epitope recognized by Thl-and Th2-type tumor-reactiveCD4+ T cells[J]. Cancer Res, 2002, 62(1):213-218.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部